Cite
HARVARD Citation
Velin, M. et al. (2022). Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real‐life study. Journal of the European Academy of Dermatology and Venereology. pp. e539-e542. [Online].